ZNF121 Inhibitors
Chemical inhibitors of ZNF121 can disrupt its function by interfering with the cellular mechanisms that regulate protein stability and degradation. Proteasome inhibitors such as MG132, Bortezomib, Epoxomicin, Lactacystin, Oprozomib, Carfilzomib, Velcade, Marizomib, Delanzomib, and Ixazomib act by preventing the proteasome from degrading polyubiquitinated proteins. Since the proteasome is responsible for the turnover of many cellular proteins, inhibiting this complex can lead to the accumulation of proteins within the cell. This accumulation can affect various signaling pathways and cellular functions, including those associated with ZNF121. If ZNF121 is normally tagged for degradation via the ubiquitin-proteasome system, the presence of these inhibitors would impede this process, leading to increased levels of the protein within the cell. The exact impact on ZNF121 will depend on its role within the proteasome pathway, but generally, this inhibition can disrupt the regulated turnover of ZNF121, affecting its function within the cell.
On the other hand, Chloroquine acts by a different mechanism, targeting the lysosomal degradation pathway. By increasing the lysosomal pH, Chloroquine can impair lysosomal enzymes that are crucial for protein degradation. If ZNF121 undergoes lysosomal degradation, the action of Chloroquine would result in reduced breakdown of the protein in this compartment, potentially leading to its accumulation. Similarly, MLN4924 targets the NEDD8-activating enzyme, which is part of the neddylation process that modifies proteins after translation. Neddylation can control the location, activity, and overall stability of proteins. If ZNF121 is regulated by neddylation, MLN4924 would disrupt this process, indirectly affecting the stability and function of ZNF121. By inhibiting these cellular processes, the selected chemicals can influence the stability and function of ZNF121 without directly targeting the protein itself.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can lead to the accumulation of ubiquitinated proteins, thereby potentially disrupting the protein degradation pathway that ZNF121 relies on for regulation, indirectly inhibiting ZNF121 by preventing its turnover. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By alkalizing the lysosomal pH, Chloroquine can interfere with the lysosomal degradation pathways. If ZNF121 is subjected to lysosomal degradation, this would inhibit its function by disrupting its degradation process. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome inhibitor can prevent the degradation of polyubiquitinated proteins, potentially causing an accumulation that inhibits the function of ZNF121 by disrupting the proteasomal degradation pathway it depends on. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
A selective proteasome inhibitor that can inhibit the degradation of proteins involved in various signaling pathways. This inhibition can indirectly inhibit ZNF121 by disrupting the proteasomal pathway necessary for its function. | ||||||
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
As a specific inhibitor of the proteasome, Lactacystin can prevent the proteolytic degradation of proteins, potentially leading to the functional inhibition of ZNF121 by interfering with its proteasomal degradation. | ||||||
Oprozomib | 935888-69-0 | sc-477447 | 2.5 mg | $280.00 | ||
By inhibiting the proteasome, Oprozomib can interfere with the degradation of proteins, potentially inhibiting ZNF121 indirectly by preventing the degradation pathway essential for its function. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $41.00 | ||
Carfilzomib inhibits the proteasome, which could lead to the accumulation of proteins that require degradation for cellular homeostasis, thus indirectly inhibiting ZNF121 by disrupting its normal degradation process. | ||||||
Delanzomib, free base | 847499-27-8 | sc-396774 sc-396774A | 5 mg 10 mg | $160.00 $300.00 | ||
Delanzomib inhibits the proteasome, which could lead to an accumulation of proteins requiring degradation, indirectly inhibiting ZNF121 by disrupting the proteasome-dependent degradation pathway. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of the NEDD8-activating enzyme that affects neddylation, a post-translational modification. If ZNF121 is subjected to neddylation, MLN4924 would inhibit its function by interfering with this modification process. | ||||||
Ixazomib | 1072833-77-2 | sc-489103 sc-489103A | 10 mg 50 mg | $311.00 $719.00 | ||
Ixazomib inhibits the proteasome, which may lead to the accumulation of proteins and disruption of the cellular protein degradation pathways, indirectly inhibiting the function of ZNF121 by interfering with its degradation. | ||||||